BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12710527)

  • 1. Modulation of L-type Ca2+ channels in neonatal rat heart by a novel Ca2+ channel agonist.
    Chahine M; Sculptoreanu A; Varma DR
    Can J Physiol Pharmacol; 2003 Feb; 81(2):135-41. PubMed ID: 12710527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of L-type Ca2+ channel by mitochondrial Na+-Ca2+ exchange inhibitor CGP-37157 in rat atrial myocytes.
    Thu le T; Ahn JR; Woo SH
    Eur J Pharmacol; 2006 Dec; 552(1-3):15-9. PubMed ID: 17054940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crotoxin potentiates L-type calcium currents and modulates the action potential of neonatal rat cardiomyocytes.
    Zhang P; Lader AS; Etcheverry MA; Cantiello HF
    Toxicon; 2010 Jun; 55(7):1236-43. PubMed ID: 20122949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-gated calcium channel currents in type I and type II hair cells isolated from the rat crista.
    Bao H; Wong WH; Goldberg JM; Eatock RA
    J Neurophysiol; 2003 Jul; 90(1):155-64. PubMed ID: 12843307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained beta-adrenergic stimulation increased L-type Ca2+ channel expression in cultured quiescent ventricular myocytes.
    Akuzawa-Tateyama M; Tateyama M; Ochi R
    J Physiol Sci; 2006 Apr; 56(2):165-72. PubMed ID: 16839451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toosendanin, a triterpenoid derivative, acts as a novel agonist of L-type Ca2+ channels in neonatal rat ventricular cells.
    Li MF; Shi YL
    Eur J Pharmacol; 2004 Oct; 501(1-3):71-8. PubMed ID: 15464064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes.
    Lalevée N; Rebsamen MC; Barrère-Lemaire S; Perrier E; Nargeot J; Bénitah JP; Rossier MF
    Cardiovasc Res; 2005 Aug; 67(2):216-24. PubMed ID: 15919070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of (S)-amlodipine and (R)-amlodipine on L-type calcium channel current of rat ventricular myocytes and cytosolic calcium of aortic smooth muscle cells.
    Wang RX; Jiang WP; Li XR; Lai LH
    Pharmazie; 2008 Jun; 63(6):470-4. PubMed ID: 18604992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of action potential and L-type calcium channel current of Sprague-Dawley rat ventricular myocytes by different amlodipine isomers.
    Wang RX; Jiang WP
    Can J Physiol Pharmacol; 2008 Sep; 86(9):620-5. PubMed ID: 18758511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identical inhibitory modulation of A-type potassium currents by dihydropyridine calcium channel agonists and antagonists.
    Mlinar B; Enyeart JJ
    Mol Pharmacol; 1994 Oct; 46(4):743-9. PubMed ID: 7969054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist specific L-type Ca(2+)-current stimulation in ventricular myocytes by a novel steroid-like compound.
    Keller M; Pignier C; Santelli M; Vacher B; Niggli E; Egger M
    Cell Calcium; 2006 May; 39(5):425-33. PubMed ID: 16540165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
    Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of L-type Ca2+ currents in rat cardiac myocytes.
    Markevich NI; Korystova AF; Grichenko AS; Lankina DA; Kokoz YM
    Membr Cell Biol; 2000; 14(1):109-27. PubMed ID: 11051087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes.
    Bai CX; Namekata I; Kurokawa J; Tanaka H; Shigenobu K; Furukawa T
    Circ Res; 2005 Jan; 96(1):64-72. PubMed ID: 15569827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes.
    Viola HM; Arthur PG; Hool LC
    J Mol Cell Cardiol; 2009 Jun; 46(6):1016-26. PubMed ID: 19166857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.